文件类型:PDF文档
文件大小:224K
This invention concerns an ophthalmic solution including : at least one prostaglandin; a solubilizing agent; a gelling agent of the carbomer type; a carbomer polymerization-inhibiting agent; a co-gelling/co-solubilizing agent.